PremiumCompany AnnouncementsAstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis1d agoAZN
PremiumCompany AnnouncementsAstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch2d agoAZN
PremiumThe FlyAstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated2d agoAZN
PremiumMarket NewsVanguard Dividend ETFs Comparison: VYMI vs. VIG vs. VYM for Income Investors3d agoJPMNVS
PremiumCompany AnnouncementsAstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study3d agoAZN